Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry.

Back

ESC Professional Premium Access

Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry.

Session: Platelets and more

Topic: Pharmacotherapy

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Uwe Zeymer

Foundation Institute for Heart Attack Research, Ludwigshafen (Germany)

19 presentations

3 followers

8 more presentations in this session

Clopidogrel monotherapy following dual antiplatelet therapy in patients with acute coronary syndrome post-drug-eluting stent implantation: a systematic review and direct/indirect treatment comparison

Speaker: Professor D. Sibbing (Munich, DE)

Access

Abstract

Slides

Ticagrelor or prasugrel in patients with acute coronary syndrome and prior myocardial infarction

Speaker: Doctor M. Scalamogna (Napoly, IT)

Access

Abstract

Slides

Antithrombotic and proton pump inhibitor co-therapy in patients with atrial fibrillation and stable coronary disease: a post hoc analysis of the AFIRE trial

Speaker: Doctor H. Wada (Izunokuni, JP)

Access

Abstract

Slides

Clinical significance of time-varying on-treatment platelet reactivity after percutaneous coronary intervention

Speaker: Professor Y. Jeong (Gwangmyeong, KR)

Access

Abstract

Slides

Beta-blockers in acute coronary syndrome: does rhythm matter?

Speaker: Doctor C. Carvalho (Vila Real, PT)

Access

Abstract

Slides

Access the full session

Platelets and more

Speakers: Professor U. Zeymer, Professor D. Sibbing, Doctor M. Scalamogna, Doctor H. Wada, Professor Y. Jeong...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources